Investor Ideas, Trading Ideas and Stocks to Watch : #AIEye #Podcast 505: GBT Tokenize (OTCPINK: $GTCH) Researching #AI Detection System and Datametrex (TSXV: $DM.V) to Acquire 100% of Concierge Medical Consultants; #artificialintelligence

Thursday, January 07, 2021

#AIEye #Podcast 505: GBT Tokenize (OTCPINK: $GTCH) Researching #AI Detection System and Datametrex (TSXV: $DM.V) to Acquire 100% of Concierge Medical Consultants; #artificialintelligence

#AIEye #Podcast 505: GBT Tokenize (OTCPINK: $GTCH) Researching #AI Detection System and Datametrex (TSXV: $DM.V) to Acquire 100% of Concierge Medical Consultants; #artificialintelligence

Global Intelligent Drug Discovery Market to Reach $3.71 Billion by 2027

Point Roberts WA, Vancouver BC – January 7, 2021 – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye- watching stock news, deal tracker and advancements in artificial intelligence – featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2021/010721-AI-Eye.mp3

Read this in full at https://www.investorideas.com/news/2021/artificial-intelligence/01071GTCH-Datametrex.asp

Hear the Ai Eye on Spotify

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (OTCPINK:GTCH) (TSXV:DM)

GBT Tokenize Corp, the joint venture of GBT Technologies Inc. (OTC PINK:GTCH), is continuing research on an AI system to detect and open clogs within arteries based on its proprietary radio technology, which has an internal code name of "Hermes". Danny Rittman, GBT’s CTO, explained:

"Our AI technology can be implemented in a wide variety of applications to control mechanical, optical and electrical systems, analyzing arterial data and making decisions in real time. We are commencing research - code name Hermes, to use our AI capabilities to search, identify and remove plaque within arteries and blood vessels. In this project, we are researching the ability to use GBT Tokenize's AI technology to control a mini-probe unit that will be inserted into a human body through a main artery. If our research is positively concluded, we believe that this type of system can be a breakthrough within the cardiovascular domain, offering less invasive treatments and introducing a new method to save lives. Artificial Intelligence technology encapsulates the future health care and we're investing vast efforts to utilize our experience and knowledge in this domain."

Datametrex AI Limited (TSXV:DM) has entered into a binding Letter of Intent to acquire 100 percent of Concierge Medical Consultants Inc., described in the press release as “an arm's length private telehealth and medical concierge services company.” Datametrex CEO Marshall Gunter said:

"The significance of the acquisition of this medical business cannot be understated. The demand for telehealth and concierge medical service is expected to continue to strengthen as the market for remote healthcare grows. We look forward to working with Dr. Sharif (founder and CEO of Concierge Medical Consultants) and his medical team to grow this business under Datametrex."

Global Intelligent Drug Discovery Market to Reach $3.71 Billion by 2027

A report published by Emergen Research finds that the global Intelligent Drug Discovery market will grow from $258.9 million in 2019 to $3.71 billion by 2027 with a compound annual growth rate (CAGR) of 39.4 percent in the forecast period. An excerpt from the report synopsis outlines the role of AI in the market:

Artificial intelligence is commonly used in the development of novel drugs. The market manufacturers are investing in partnerships and collaborations to drive the demand for technology. It reduces time as well as the overall cost of the drug development procedure, which makes it attractive among pharmaceutical companies. The dearth of a skilled professional and lack of data sets are hindering its growth. Furthermore, increasing awareness of the integration of AI in the healthcare industry will offer growth opportunities to the market.

Sam Mowers, Investorideas.com

Read and hear other editions of the AI Eye

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.

About GBT Technologies Inc.

GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development-stage company which considers itself a native IoT creator, developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology platforms. GBT has a portfolio of Intellectual Property that, when commercialized, will include smart microchips, mobile and security applications and protocols, and supporting cloud software. GBT’s system envisions the creation of a global mesh network. The core of the system will be its advanced microchip technology that can be installed in any mobile or fixed device worldwide. GBT envisions this system as a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing and enhanced mobile features as an alternative to traditional carrier services.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .

The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Disclosure: GTCH is a paid monthly ai stock on investor ideas

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence is an original content brand of Investorideas.com